1-5 of 5
Michael Kramer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML

Julia Marie Unglaub, Richard F. Schlenk, Jan M Middeke, Stefan W Krause, Sabrina Kraus, Hermann Einsele, Michael Kramer, Sven Zukunft, Joseph Kauer, Simon Renders, Elena Katelari, Christoph Schliemann, Caroline Pabst, Thomas Luft, Peter Dreger, Christoph Röllig, Martin Bornhäuser, Carsten Müller-Tidow, Tim Sauer
Journal: Blood Advances
Blood Adv bloodadvances.2024013086.
https://doi.org/10.1182/bloodadvances.2024013086
Published: 2024
Includes: Supplemental data
Journal Articles

Deep sequencing in CD34 + cells from peripheral blood enables sensitive detection of measurable residual disease in AML

Sebastian Stasik, Clara Burkhard-Meier, Michael Kramer, Jan M. Middeke, Uta Oelschlaegel, Katja Sockel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Claudia D. Baldus, Christoph Röllig, Martin Bornhäuser, Uwe Platzbecker, Christian Thiede
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3294–3303.
https://doi.org/10.1182/bloodadvances.2021006233
Published: 2022
Includes: Supplemental data
Journal Articles

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

Clinical Trials & Observations
Raphael Teipel, Frank Kroschinsky, Michael Kramer, Theresa Kretschmann, Katharina Egger-Heidrich, Thomas Krüger, Leo Ruhnke, Sylvia Herold, Sebastian Stasik, Katja Sockel, Jan M. Middeke, Karolin Trautmann-Grill, Martin Bornhäuser, Christian Thiede, Malte von Bonin
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1941–1946.
https://doi.org/10.1182/bloodadvances.2021005747
Published: 2022
Includes: Supplemental data
Journal Articles

Differential impact of IDH1 / 2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Clinical Trials & Observations
Jan M. Middeke, Klaus H. Metzeler, Christoph Röllig, Michael Krämer, Jan-Niklas Eckardt, Sebastian Stasik, Philipp A. Greif, Karsten Spiekermann, Maja Rothenberg-Thurley, Utz Krug, Jan Braess, Alwin Krämer, Andreas Hochhaus, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Dennis Görlich, Cristina Sauerland, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Martin Kaufmann, Desiree Kunadt, Bernhard Wörmann, Katja Sockel, Malte von Bonin, Tobias Herold, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Claudia D. Baldus, Gerhard Ehninger, Johannes Schetelig, Wolfgang Hiddemann, Martin Bornhäuser, Friedrich Stölzel, Christian Thiede
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1394–1405.
https://doi.org/10.1182/bloodadvances.2021004934
Published: 2022
Includes: Supplemental data
Journal Articles

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Clinical Trials & Observations
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede, on behalf of the Study Alliance Leukemia (SAL)
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3279–3289.
https://doi.org/10.1182/bloodadvances.2021004631
Published: 2021
Includes: Supplemental data